068270:KRX
Celltrion Inc
₩180,300.00
arrow_downward
-1.53%(-2,800.00) 1D
Sep 10, 2:17:27 PM GMT+9 · KRW
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for 068270...
Open
₩181,800
High
₩183,500
Low
₩180,100
Mkt. cap
41.94T
Avg. vol.
593.58K
Volume
343.64K
Dividend
0.40%
Quarterly dividend
₩179
Ex-dividend date
Dec 29, 2025
P/E ratio
26.35
52-wk high
₩239,047
52-wk low
₩158,500
EPS
₩6,842
Shares outstanding
232.62M
No. of employees
3K
Open
₩181,800
High
₩183,500
Low
₩180,100
Mkt. cap
41.94T
Avg. vol.
593.58K
Volume
343.64K
Dividend
0.40%
Quarterly dividend
₩179
Ex-dividend date
Dec 29, 2025
P/E ratio
26.35
52-wk high
₩239,047
52-wk low
₩158,500
EPS
₩6,842
Shares outstanding
232.62M
No. of employees
3K
News stories
From web sources and news partners
BigGo Finance
·
2 hours ago
Celltrion's Omlyclo Builds Distribution Network Across 26 European Countries; Spain Market Share Tops 90%
Seoul Economic Daily
·
3 hours ago
Celltrion's Omlyclo Reaches 26 European Countries, Tops 90% Share in Spain
Chosunbiz
·
5 hours ago
Celltrion boosts Europe sales as Omlayclo seizes 90% Spain share - CHOSUNBIZ
Profile
Celltrion, Inc. is a biopharmaceutical company headquartered in Incheon, South Korea. Celltrion Healthcare conducts worldwide marketing, sales, and distribution of biological medicines developed by Celltrion. Celltrion's founder, Seo Jung-jin, is the richest person in South Korea. Seo Jung-jin, its founder was awarded the 2021 EY World Entrepreneur Of The Year. Wikipedia
About Celltrion Inc